Company Overview and News

 
Bank of Singapore to double wealth management staff in Hong Kong to cater to China’s rich

2018-04-17 scmp
Bank also plans to set up family offices in major Chinese cities this year to help the wealthy with inheritance planning
Upvote Downvote

 
Wealth assets at private banks in Asia surge above US$2 trillion

2018-04-13 thestar.com.my
SINGAPORE: Assets under management (AUM) at private banks in Asia surged 29% last year to top US$2 trillion for the first time, driven by strong flows from China and buoyant financial markets, according to Asian Private Banker.
Upvote Downvote

 
Wealth assets at private banks in Asia surge above US$2 trillion

2018-04-12 thestar.com.my
SINGAPORE: Assets under management at private banks in Asia surged 29% last year to top US$2 trillion for the first time, driven by strong flows from China and buoyant financial markets, according to Asian Private Banker. “Asia’s private banks benefited from a sustained market rally and robust client activity to deliver strong AUM growth and, in many cases, post record revenues,” said Sebastian Enberg, editor of the Hong Kong-based publication.
Upvote Downvote

 
China’s Ball of Money Rolls From Stocks to Bonds - Bloomberg

2018-04-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Brace Yourself For Chinese Tech IPOs

2018-04-10 seekingalpha
Several mega-funded Chinese tech startups are poised to public this year or next. Among them are: ride sharing service Didi Chuxing, smart gadget maker Xiaomi, merged e-ecommerce sites Meituan-Dianping, and news aggregator ByteDance. The combined market capitalization of these new listers could well surpass a quarter-trillion dollars, according to an article in Silicon Dragon News. Who are these companies?
Upvote Downvote

 
ASHR: Index Changes Make This ETF A Less Compelling Option

2018-04-06 seekingalpha
Chinese shares are divided into several different share classes. Until recently, mainland Chinese listings of A-Shares were largely out of reach of non-Chinese investors.
Upvote Downvote

 
Is a UK model ‘with Chinese characteristics’ the answer for financial regulation?

2018-03-29 scmp
Researchers say British system introduced in 2013 could be a good reference for Beijing as it tries to shake up oversight and control risk
Upvote Downvote

 
CMB eyes asset offshoot – ValueWalk Premium

2018-03-29 valuewalkpremium
Bank’s proposed wholly-owned wealth management arm to help counter risk China Merchants Bank (CMB) is looking to set up a wholly-owned asset management arm, the first commercial bank to do so if it is approved, in response to regulators’ ramping up efforts to counter risks linked to a vast shadow banking sector. In the guideline on…
Upvote Downvote

 
Nuts. China Is Hoarding Unicorns and Breeding Squirrels - Bloomberg

2018-03-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Five Things You Need to Know to Start Your Day - Bloomberg

2018-03-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Zero To Sixty: The Rise Of China In Global Indexes

2018-03-22 seekingalpha
Five years ago, on a cold winter day in Beijing, KraneShares' founder, Jonathan Krane, and I had a meeting at the offices of China's top financial regulator, the China Securities Regulatory Commission (CSRC), that would prove to be one of the highlights of my 17 years working in the ETF industry. During the meeting, we introduced the idea of listing an exchange traded fund in New York comprised of stocks listed on the Shanghai and Shenzhen Stock Exchanges (A-shares).
Upvote Downvote

 
These emerging-market fund managers focus on the explosive growth of consumer spending - MarketWatch

2018-03-21 marketwatch
Tom Masi and Nuno Fernandes, managers of the Trilogy Emerging Wealth Equity Fund, focus on consumer consumption in emerging markets. That has led them to varied investments such as a retro-motorcycle company, a high-alcohol liquor producer and a digital-payment firm.
Upvote Downvote

 
China Merchants Port: Selldown Post Tariff Cuts Overdone

2018-03-02 seekingalpha
China Merchants Port is a leading port operator in China. It has presence in 8 of the top 10 container ports in China.
Upvote Downvote

 
China's Export Machine Is Taking On a Stronger Yuan, and Winning - Bloomberg

2018-02-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
China’s export machine taking on stronger yuan, and winning

2018-02-27 themalaymailonline
While a rising yuan over time makes exports more expensive, China's trade isn’t suffering yet. — Reuters picBEIJING, Feb 27 — China’s exporters are shrugging off the surging yuan, even as it nears its strongest level since 2015.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...